Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

254 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

A Study to Assess the Clinical Efficacy of Donidalorsen (Also Known as IONIS-PKK-LRx and ISIS 721744) in Participants With Hereditary Angioedema

NCT04030598

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • University of California San Diego (UCSD) San Diego, California, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
  • Midwest Immunology Clinical Plymouth, Minnesota, United States
View Trial Details
Completed

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

NCT03845400

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
View all 29 locations
View Trial Details
Completed

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

NCT04861090

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • LKH-Universitätsklinikum Klinikum Graz Graz, Austria
  • Kepler Universitätsklinikum Linz Linz, Austria
  • Medizinische Universitat Wien (Medical University of Vienna) Vienna, Austria
  • CHU de Grenoble Grenoble, France
View all 20 locations
View Trial Details
Completed

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

NCT01998633

Conditions
Blood Protein Disorders, Chronic Active Epstein-Barr Virus Infection, Chronic Disease, +26 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 22 locations
View Trial Details
Completed

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

NCT03712228

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Donald S. Levy Orange, California, United States
  • Allergy & Asthma Clinical Research Walnut Creek, California, United States
  • Immunoe Health Centers Centennial, Colorado, United States
  • Institute for Asthma and Allergy Chevy Chase, Maryland, United States
View all 16 locations
View Trial Details
Completed

Human Placental-Derived Stem Cell Transplantation

NCT01586455

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
Locations
  • Children's Hospital Colorado Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
  • University of Utah Salt Lake City, Utah, United States
View Trial Details
Completed

Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)

NCT04180163

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Toyohashi Municipal Hospital Toyohashi, Aichi-ken, Japan
  • Asahi General Hospital Asahi-shi, Chiba, Japan
  • Ogaki Municipal Hospital Ogaki-shi, Gifu, Japan
  • Hiroshima University Hospital Hiroshima, Japan
View Trial Details

Related conditions